Literature DB >> 17974944

The use of olanzapine in pregnancy and congenital cardiac and musculoskeletal abnormalities.

Yonatan Yeshayahu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974944     DOI: 10.1176/appi.ajp.2007.07010176

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

Review 1.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

2.  Novel report on congenital talipes equinovarus (CTEV) following olanzapine exposure during pregnancy: case report and short review.

Authors:  Rajan Gyawali; Ashok Baral; Dikshya Upreti; Chandra Bhushan Yadav; Anoop Krishna Gupta; Miyuru Chandradasa; Sheikh Shoib
Journal:  Arch Womens Ment Health       Date:  2022-03-14       Impact factor: 3.633

Review 3.  Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.

Authors:  Elizabeth Brunner; Deborah M Falk; Meghan Jones; Debashish K Dey; Chetan Chinmaya Shatapathy
Journal:  BMC Pharmacol Toxicol       Date:  2013-08-01       Impact factor: 2.483

4.  Tracheo-Esophageal Fistula (TEF) in a Newborn Following Maternal Antenatal Exposure to Olanzapine.

Authors:  Vikas Maharshi; Indranil Banerjee; Pravesh Nagar; Harmeet Singh Rehan
Journal:  Drug Saf Case Rep       Date:  2017-12

5.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

Review 6.  Mood stabilizers in pregnancy and lactation.

Authors:  Sandeep Grover; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2015-07       Impact factor: 1.759

Review 7.  Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature.

Authors:  Andreea Teodorescu; Petru Ifteni; Marius Alexandru Moga; Victoria Burtea; Nicusor Bigiu
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.